| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 313 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial J Frater, KJ Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ... The lancet HIV 8 (8), e474-e485, 2021 | 248 | 2021 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 207* | 2022 |
| T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses A Ogbe, B Kronsteiner, DT Skelly, M Pace, A Brown, E Adland, K Adair, ... Nature communications 12 (1), 2055, 2021 | 131* | 2021 |
| The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses SM Murray, AM Ansari, J Frater, P Klenerman, S Dunachie, E Barnes, ... Nature Reviews Immunology 23 (5), 304-316, 2023 | 123 | 2023 |
| Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies MA Moody, I Pedroza-Pacheco, NA Vandergrift, C Chui, KE Lloyd, ... Science immunology 1 (1), aag0851-aag0851, 2016 | 121 | 2016 |
| Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, ... Nature communications 11 (1), 6385, 2020 | 117 | 2020 |
| Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation T Miao, ALJ Symonds, R Singh, JD Symonds, A Ogbe, B Omodho, B Zhu, ... Journal of Experimental Medicine 214 (6), 1787-1808, 2017 | 68 | 2017 |
| Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors CM Nielsen, A Ogbe, I Pedroza-Pacheco, SE Doeleman, Y Chen, SE Silk, ... Cell Reports Medicine 2 (3), 2021 | 47 | 2021 |
| Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV A Ogbe, M Pace, M Bittaye, T Tipoe, S Adele, J Alagaratnam, PK Aley, ... JCI insight 7 (7), e157031, 2022 | 45 | 2022 |
| Immune checkpoint modulation enhances HIV-1 antibody induction T Bradley, M Kuraoka, CH Yeh, M Tian, H Chen, DW Cain, X Chen, ... Nature communications 11 (1), 948, 2020 | 36 | 2020 |
| Divergent trajectories of antiviral memory after SARS-CoV-2 infection A Tomic, DT Skelly, A Ogbe, D O’Connor, M Pace, E Adland, F Alexander, ... Nature communications 13 (1), 1251, 2022 | 33 | 2022 |
| Epigenetic features of HIV-induced T-cell exhaustion persist despite early antiretroviral therapy GE Martin, DR Sen, M Pace, N Robinson, J Meyerowitz, E Adland, ... Frontiers in immunology 12, 647688, 2021 | 33 | 2021 |
| Early growth response genes 2 and 3 regulate the expression of Bcl6 and differentiation of T follicular helper cells A Ogbe, T Miao, ALJ Symonds, B Omodho, R Singh, P Bhullar, S Li, ... Journal of Biological Chemistry 290 (33), 20455-20465, 2015 | 33 | 2015 |
| Booster vaccination against SARS-CoV-2 induces potent immune responses in people with human immunodeficiency virus S Fidler, J Fox, T Tipoe, S Longet, T Tipton, M Abeywickrema, S Adele, ... Clinical Infectious Diseases 76 (2), 201-209, 2023 | 21 | 2023 |
| Harnessing natural killer cell innate and adaptive traits in HIV infection A Alrubayyi, A Ogbe, E Moreno Cubero, D Peppa Frontiers in cellular and infection microbiology 10, 395, 2020 | 16 | 2020 |
| The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific … MJ Lee, S Collins, D Babalis, N Johnson, E Falaschetti, AT Prevost, ... Trials 23 (1), 263, 2022 | 14 | 2022 |
| A seat at the table is not enough: a perspective on Black women representation in academia A Ogbe Immunology and cell biology 100 (9), 679-682, 2022 | 13 | 2022 |
| Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... MedRxiv, 2022.06. 06.22275865, 2022 | 8 | 2022 |
| Subordinate effect of-21M HLA-B dimorphism on NK cell repertoire diversity and function in HIV-1 infected individuals of African origin EM Cubero, A Ogbe, I Pedroza-Pacheco, MS Cohen, BF Haynes, ... Frontiers in Immunology 11, 156, 2020 | 8 | 2020 |
John FraterUniversity of Oxfordכתובת אימייל מאומתת בדומיין ndm.ox.ac.uk